Showing posts with label Cancer colon. Show all posts
Showing posts with label Cancer colon. Show all posts

Monday, November 21, 2022

Modern management of obstructive colon cancer in the background of ulcerative colitis

 


 An elderly patient with history of treatment for ulcerative colitis for over 2 decades presented to emergency with acute intestinal obstruction. Contrast enhanced abdominal CT scan was suggestive of large bowel obstruction with stricture in proximal sigmoid colon. The patient underwent sigmoidoscopy with self-expanding metallic stent (SEMS) placement as bridge to elective surgery. The biopsy was suggestive of adenocarcinoma in the background of ulcerative colitis (UC). Further oncology work up including whole body PET scan did not reveal any metastatic disease. Two weeks later, laparoscopy assisted total proctocolectomy with ileal pouch anal anastomosis was performed. The postoperative period was uncomplicated and the patient was discharged on 7th postoperative day. The biopsy revealed moderately differentiated adenocarcinoma T3N0 (> 20 regional lymph nodes examined) in the background of ulcerative colitis. All surgical margins were clear (Figure 1).

Figure1. Proctocolectomy specimen

This case highlights the importance of regular follow up (including surveillance colonoscopy) for patients with ulcerative colitis.

SEMS are increasingly utilized in malignant left colonic obstructions as bridge to elective surgery. A recent meta-analysis of 33 studies involving 15224 patients compared the outcomes of emergency resection, diverting stoma and SEMS placement for obstructing left colon cancer.1 A bridging interval of 02 weeks following SEMS placement has been reported as appropriate.2

A recent systematic review and meta-analysis (25 studies) compared the survival outcomes of inflammatory bowel disease (IBD) associated (8034 patients) and non IBD associated (810526 patients) colorectal cancer (CRC). Cancer specific survival for IBD – CRC was poorer than those without IBD. Of the IBD – CRC patients, UC patients had favorable overall survival when compared to Crohn’s disease patients. The IBD associated CRC was characterized by increased rate of unfavorable histologic features such as poor differentiation and signet ring carcinoma, right sided tumors and reduced rate of R0 resections.3

Development of colorectal cancer is one of the most serious complication of ulcerative colitis. Cumulative risk of development of cancer reaches 25% at 25 years, rising up to 65% at 40 years of disease duration. Patients with involvement of entire colon have increased risk as compared to those with disease confined to the left side of the colon. A surveillance colonoscopy is recommended every 1-2 years beginning 8 years after pancolitis and 12-15 years after the onset of left sided colitis.4

 

References

1.       Jain SR, Yaow C Y L, Ng CH. Comparison of colonic stents, stomas and resection for obstructive left colon cancer: a meta-analysis. Tech Coloproctol 2020;24(11); 1121-1136

2.       Velde J V, Kumcu A, Amlung F J et al. Time interval between self-expandable metal stent placement or creation of a decompressing stoma and elective resection of left-sided obstructive colon cancer Endoscopy 2021; 53(9):905 -13

            3.    Can Lu, Josefine S, Zhang T et al. Survival outcomes and clinicopathological features in                 inflammatory bowel disease associated colorectal cancer. A systematic review and meta-                analysis. Ann Surg 2022;276(5):e319-330
    4.    Townsend CM, Beauchamp RD, Evers BM, Mattox KL (2017) Sabiston textbook of surgery,             first south asia edition (20th edition). Elsevier Page 1342


Authors:
Dr Nitin Vashistha, MS, FIAGES, FACS
Dr Dinesh Singhal, MS, FACS, DNB (Surg Gastro)

Department of Surgical Gastroenterology,
Max Super Speciality Hospital, Saket, New Delhi, India
E mail: gi.cancer.india@gmail.com

Friday, May 15, 2020

Surgery for colorectal cancer (CRC) with first presentation as bowel obstruction


According to international statistics, colorectal cancer (CRC) is the third most commonly diagnosed cancer in males and second in females.1 However in India lies, the incidence is lower as compared in Europe and North America. According to ICMR consensus document on management of CRC (2014), colon cancer ranks as 8th and rectal cancer as 9th among men and amongst women colon cancer ranks 9th while cancer rectum does not figure in top 10 cancers.
First presentation of CRC as emergency – obstruction, perforation or bleeding is not uncommon. Malignant large bowel obstruction is reported in 8-13% patients with CRC In Western studies.2,3 Another multicentre study from UK involving 286591 patients over a 15 year period (1997 – 2012) reported  that 24.3% (69718 patients) needed emergency for CRC and all cause 30 and 90 day mortality was significantly higher in patients undergoing emergency surgery as compared to elective surgery.4
 Management of such patients is particularly challenging as they are often elderly with significant comorbidity and histopathologic diagnosis may not be unavailable. At surgery large bowel may be hugely distended and complex resections may be required.
In the following sections, we briefly discuss the management CRC presenting as emergency through a representative case series of patients wherein the first presentation was obstruction or perforation.
Case study 1
An elderly woman in her 5th decade presented with acute intestinal obstruction. Her contrast enhanced abdominal computed tomography (CT) scan showed mass lesion in cecum – ascending colon (Figure 1).

Figure 1. Carcinoma right colon with acute
Intestinal obstruction
She underwent right hemicolectomy with primary anastomosis and had an uneventful recovery. The biopsy was suggestive of adenocarcinoma T3N1. She was stared on adjuvant chemotherapy after 3 weeks and is currently well 4 years after surgery.
Case study 2
An elderly woman in her 8th decade presented with 6 months history of weight loss and progressive constipation that for last 4 days had progressed to obstipation. There was no major comorbid illness and prior to obstipation she was managing her daily activities. Her abdominal CT scan revealed obstructing lesion in rectosigmoid region with closed loop obstruction. There were multiple colorectal liver metastases in segment 2 & 3 (Figure 2 & 3).

Figure 2. Abdominal CT scan with distended left colon and CLM

Figure 3. Abdominal CT scan showing closed obstruction of large bowel
At surgery, the whole of whole of large bowel was massively distended but the cecum was viable. Anterior resection with ascending colostomy was done. She opted for colostomy closure 8 weeks later but declined further chemotherapy. Following this second surgery she was restored to good quality of life and passed away 16 months later.
Case study 3
An elderly male with history of weight loss and progressive constipation presented to emergency room. He was a known diabetic and had undergone coronary bypass 1 year ago had low ejection fraction (35%). Abdominal CT scan is provided in Figure 4. The total white blood cell count was 39,000 mm3

Figure 4. Closed loop obstruction of large bowel with hugely distended cecum
At surgery, there was an obstructing mass lesion in sigmoid colon with infiltration of dome of urinary bladder. The cecum appeared gangrenous. A subtotal colectomy with partial cystectomy was performed. Reconstruction was by an ileorectal anastomosis with diverting loop ileostomy. He had an uneventful postoperative recovery and was discharged on 8th postoperative day. The biopsy reported adenocarcinoma sigmoid colon T4N1 with all clear surgical margins. The ileostomy was successfully reversed 8 weeks later.
Discussion
A US study (1991 – 2005) involving 1004 patients ≥65 years with stage IV colon cancer reported that obstruction occurred a median of 7.4 months after colon cancer diagnosis and median survival after obstruction was approximately 2.5 months.5 Risk factors for presentation with obstruction included proximal location, high grade tumor, mucinous histological type and nodal stage N2.3 Another study from Australia has reported that emergency patients had 5 year survival rate of 39. 2% compared to 64.7% for elective patients (p< 0.0001) and they also had significantly more advanced Dukes C & D tumors. Also both emergency Dukes B and C groups had significantly more T4 cases.6
The current treatment options for MLBO include:
1.    Endoscopic stenting with self expanding metallic stent (SEMS) placement
Endoscopic stenting with SEMS can be used as a palliative therapy in patients with unresectable primary or metastatic disease. For patients with malignant large bowel obstruction where a curative surgery is deemed feasible SEMS is used as a bridge to definitive surgery thereby avoiding risks of emergency surgery, higher chances of primary anastomosis  and avoiding permanent stomas in 30-40% patients.7.8 However SEMS placement may result in perforation rates ranging between 6.9 – 7.7%.8,9
2.    Surgery: This may be done as one, two or 3 stage procedure:
-          Single stage procedure: Oncologic resection + primary anastomosis.
This is generally acceptable for obstructing carcinoma on the right side and in select patients on left side in the form of subtotal colectomy with ileorectal anastomosis.
-          Two stage – (i) Oncologic resection with anastomosis + proximal diverting stoma (ii) stoma closure
-          Three stage – (i) Proximal diverting stoma (ii) oncologic resection of the tumor(iii) stoma closure
The choice of treatment depends on the usual combination of patient factors (e.g. age, comorbidity, hemodynamic stability, patient preference etc), tumor factors (stage, location, degree of obstruction – partial or complete, condition of the proximal bowel e.g. bowel dilatation, viability of cecum) and available local expertise.
Hence for optimal immediate and oncological outcomes such patients should always be managed by surgical teams experienced in GI oncosurgery as well as emergency GI surgery.
References
1.      Torre LA1Bray FSiegel RLFerlay JLortet-Tieulent JJemal A. Global cancer statistics 2012. CA Cancer J Clin. 2015 Mar;65(2):87-108
2.      Jeanin E. van Hooft, Joyce V. Veld, 2, Dirk Arnold et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline Update 2020. Endoscopy
3.      Winner M, Mooney SJ, Hershman DL et al. Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer. JAMA Surg 2013;148(8):715-22
4.      Askari ANachiappan SCurrie A et al. Who requires emergency surgery for colorectal cancer and can national screening programs reduce this need. Int J Surg 2017;42:60-68  
5.      Winner M, Mooney SJ, Hershman DL et al. Management and outcome of bowel obstruction in patients with stage IV colon cancer. Dis Colon Rectum. 2013 Jul; 56(7): 834–843.
6.      Wong SK1Jalaludin BBMorgan MJ. Tumor pathology and long term survival in emergency colorerectal cancer. Dis Colon Rectum. 2008 Feb;51(2):223-30
7.      Hsu J, Sevak S. Malignant large bowel obstruction. Dis Colon Rectum 2019; 62: 1028–1032
8.      Amelung FJBorstlap WAAConsten ECJ et al. Propensity score-matched analysis of oncological outcome between stent as bridge to surgery and emergency resection in patients with malignant left-sided colonic obstruction. Br J Surg 2019;106:1075-1086
9.      Tan CJ, Dasari BV, Gardiner K Systematic review and meta-analysis of randomized clinical trials of self-expanding metallic stents as a bridge to surgery versus emergency surgery for malignant left-sided large bowel obstruction. Br J Surg 2012;99:469-76


Authors:
Dr Nitin Vashistha, MS, FIAGES, FACS
Dr Dinesh Singhal, MS, FACS, DNB (Surg Gastro)

Department of Surgical Gastroenterology,
Max Super Speciality Hospital, Saket, New Delhi, India
E mail: gi.cancer.india@gmail.com



Monday, February 24, 2020

Colon cancer: Generalized peritoneal pigmentation - rare sequel of India ink tattooing


Colonoscopic tattooing of colorectal neoplasms with India ink is currently the preferred technique for tumor localization during subsequent laparoscopic resections. It is safe (complications 0.22%) and accurate (90.5 - 97.9%).1,2,3 Dye spillage occurs in 2.4 – 13 % patients and is usually asymptomatic.4
Tattooing may sometimes result in rare findings that cause diagnostic dilemma during surgery.
A 65 year old male presented with history of weight loss, recent onset constipation and bleeding of bright red per rectum for 1 year. His general physical and abdominal examination was unremarkable as was digital rectal examination and proctoscopy.
Colonoscopy revealed large polypoidal sigmoid colon tumor which was tattooed with India ink. Admittedly the tumor in our patient was large and may well have been localized without tattooing also.
Endoscopic biopsy suggested well differentiated adenocarcinoma.  Contrast enhanced abdominal computed tomography scan showed large, non obstructing tumor involving distal sigmoid colon (Figure 1).  


Figure 1: Contrast enhanced abdominal computed tomography scan showing large enhancing tumor in distal sigmoid colon

The patient was planned for laparoscopy assisted radical sigmoid colectomy.  At initial laparoscopy there were dark pigmented macules diffusely present over peritoneal cavity raising suspicion of metastatic malignant melanoma (Figure 2). 

Figure 2: Laparoscopy showing multiple pigmented patches over peritoneum with minimal free fluid

Frozen section from multiple such lesions did not reveal tumor deposits and was proceeded with. Final histopathology staging was pT2N0M0. On Hematoxylin & Eosin (H & E) staining, pigmented lesions were due to black pigment (presumably carbon from India ink) laden macrophages. Negative immunohistochemistry (IHC) for HMB45 & Melan A ruled out melanocytes as causative for pigmentation (Figure 3).
Figure 3: Microphotograph: H & E stain - showing black pigment laden macrophages; IHC HMB45 - negative for melanocytes


 The postulated mechanisms for such findings include intraperitoneal spillage of India ink or via pigment laden macrophages.5
Awareness of this entity is important for surgeons to avoid misinterpretation of peritoneal findings at laparoscopy.

References
1.       Nizam R, Siddiqi N, Landas SK, Caplan DS, Holtzapple PG. Colonic tattooing with India ink: Benefits, risks and alternatives. Am J Gastroenterol 1996;91(9):1804-08
2.       Acuna SA, Elmi M, Shah PS, Coburn NG, Quereshi FA. Preoperative localization of colorectal cancer: A systematic review and metanalysis. Surg Endosc 2017;31(6):2366-2379
3.       Cho YB, Lee WY, Yun HR, Lee WS, Yun SH, Chun HK. Tumor localization for laparoscopic colorectal surgery. World J Surg 2007;31(7):1491-5
4.       Trakarnsanga A, Akaraviputh T. Endoscopic tattooing of colorectal lesions: Is it a risk free procedure ? World J Gastrointest Endosc. 2011;3 (12):256-60
5.       Cappell MS, Courtney JT, Amin M. Black macular patches on parietal peritoneum and other extra intestinal sites from intraperitoneal spillage and spread of India ink from preoperative endoscopic tattooing: an endoscopic, surgical, gross pathologic and microscopic study. Dig Dis Sci 2010;55(9):2599-2605

Authors:
Dr Nitin Vashistha, MS, FIAGES, FACS
Dr Dinesh Singhal, MS, FACS, DNB (Surg Gastro)

Department of Surgical Gastroenterology,
Max Super Speciality Hospital, Saket, New Delhi, India
E mail: gi.cancer.india@gmail.com


Friday, July 26, 2019

Outcomes of Colorectal Surgery (CRS) at Department of Surgical Gastroenterology, Max Hospital (Saket): International quality at affordable Indian costs


Our team attended annual conference of the Society of American Gastrointestinal & Endoscopic Surgeons (SAGES) held at Baltimore, USA April 2019. We presented 3 studies including one entitled ‘Outcomes following colorectal surgery: A comparative study CR-POSSUM and ACS-NSQIP risk calculator.1
In the following section we share some of the highlights of this study.
A recent study published in New England Journal of Medicine examined 30 -day readmission data of 479,471 patients from 3004 USA hospitals undergoing six major surgical procedures (colectomy and 5 other surgical procedures). The study concluded that following major surgical procedures, nearly one in seven patients are readmitted to the hospital within 30 days of discharge and readmission data is an indicator of quality of surgical care at any hospital.2
We therefore performed audit of colorectal surgery (CRS) outcomes at our department using American College of Surgeons National Surgery Quality Improvement Program (ACS NSQIP) risk calculator - one of the most widely utilized and validated universal risk calculator for clinical audits.
The ACS NSQIP risk calculator was developed by utilizing data collected from 4.3 million operations performed across 780 hospitals participating in ACS NSQIP to predict outcomes for 1500 surgical procedures. The risk calculator estimates an individual’s risk of developing 18 different complications within 30 days after surgery.
The risk adjusted scoring systems such as ACS NSQIP risk calculator are important because in heterogeneous cohorts of surgery patients, crude postoperative morbidity and mortality as an outcome measure is misleading. Therefore, for meaningful conclusions from clinical audits and compare outcomes between different units or regions, risk adjusted patient outcomes are essential.
Our single centre observational study included 86 consecutive adult (≥ 18 years) patients who underwent elective or emergency, resective &/or reconstructive CRS from March 2013 to March 2018. Procedures such as appendicectomy, diverting colostomy, laparoscopic rectopexy were excluded from analysis. Data was accessed from institutional electronic health record system and pre-anaesthetic charts. ACS – NSQIP score for each patient was calculated. Actual outcomes were then compared with those predicted by risk calculators.
Of the 86 patients (60 Indians and 26 International) there were 56 males and 30 females with a mean age of 57 (range 18-93) years. Of these 59 (68.6%) underwent elective whereas 27(31.4%) had emergency CRS. We performed complete range of procedures for cancer as well as benign diseases. Sixty-two (72%) and 24 (38%) patients underwent open and minimally invasive procedures (laparoscopic -21 and robotic -3) respectively. The median length of stay was 08 (range 02-40) days. The mortality following elective and emergency operations was 1/59 (1.6%) and 8/27(29.6%) respectively. The readmission rate was 05 (5.8%)
Objective comparison between overall actual outcomes and those predicted by ACS – NSQIP risk calculator revealed no statistically significant difference in any of the parameters studied such as mortality, major complication, anastomotic leak, return to OT, surgical site infection length of stay, and readmission (Figure 1). 

Figure 1. Actual versus predicted outcomes by ACS-NSQIP risk calculator

Additionally there is significant cost advantage - all-inclusive costs of surgery (admission to discharge) were one fifth of the costs incurred for colectomy at comparable US NSQIP hospitals (Figure 2).

Figure 2. Comparison of costs for Colectomy at MSSH & US NSQIP hospitals

In conclusion at Department of Surgical Gastroenterology, Max Super Speciality Hospital, Saket outcomes of colorectal surgery are comparable to best of international centres - US NSQIP hospitals at affordable Indian costs.


References:
1. Vashistha N, Verma A and Singhal D. Outcomes following colorectal surgery: A comparative study CR-POSSUM and ACS-NSQIP risk calculator. Surg Endosc. 2019;33:S241
2. Tsai TC, Joynt KE, Orav EJ et al. Variation in surgical readmission rates and quality of hospital care. N Engl J Med 2013;369:1134-42
      
      Authors:

Dr Nitin Vashistha MS, FIAGES, FACS
Dr Dinesh Singhal MS, FACS, DNB (Surg Gastro)
Department of Surgical Gastroenterology,
Max Super Speciality Hospital, Saket, New Delhi, India
E mail: gi.cancer.india@gmail.com



Monday, July 22, 2019

Tips & Tricks for Safe Anastomosis in Minimally Invasive Colorectal Surgery

Part B.   Intraoperative assessment of anastomotic integrity
This is second part in series of the blog 'Tips & tricks for safe anastomosis in minimally invasive colorectal surgery' (https://gicancerindia.blogspot.com/2019/07/tips-tricks-for-safe-anastomosis-in.html).
Anastomotic leak (AL) is the most feared complication of colorectal anastomosis (CRA) with a reported incidence of 8.1% after right hemicolectomy and 5.8% after high anterior resection and 10.8% after low anterior resection1.
The attributes of 'Safe' intestinal anastomosis include tension free anastomosis between well vascularised bowel segments. In the era of open surgery, surgeons assessed the latter by a combination of observation (' healthy' color and pulastile bleeding at cut end of the bowel) and palpation (arterial pulsations in the mesocolon). In MIS, options available to the surgeons are more limited and viability of the colon following resection and subsequent anastomosis is determined largely by observing the color.
However the predictive accuracy of surgeons' clinical risk assessment for AL is reported to be low and is not influenced by training level (surgeon versus assistant surgeons)2.
To make this assessment less observer dependent and to more objectively assess anastomotic integrity and tissue perfusion, several intraoperative tests have been introduced in clinical practice over last few years.
1.       Intraoperative air leak test (ALT): For left sided anastomosis, the test is simple and performed by insufflating the rectum with air while submerging the anastomosis3.
2.       Intraoperative flexible sigmoidoscopy for assessment of colorectal anastomosis (CRA): This is a safe and reliable method for direct assessment of anastomotic integrity as well as bleeding 4. More commonly performed in units where surgeons themselves are trained to perform colonoscopy.
3.       Intraoperative Indocyanine Green (ICG) fluorescence imaging: Intraoperative ICG imaging is a simple reproducible technique for real time assessment intestinal perfusion 1. The data from non randomized studies on the subject suggests decreased anastomotic leak following ICGA5,6. However results of a recent multicenter randomized controlled trial from Italy suggests that while ICGA can effectively assess vascularisation of the colic stump and anastomosis and led to further proximal resection in 11% of patients, there was no statistically significant reduction of anastomotic leak in the ICGA arm2 . Further one multicenter phase II trial investigating the role of ICG imaging in elective CRS has reported that while the technique helped reduce AL rates in left sided resections  - particularly LAR, it did not add any value to outcomes following  ileocolic anastomoses 1 .
Comments: We routinely do the intraoperative ALT for left sided anastomoses. For the right side, we perform extracorporeal anastomosis and have not introduced ICG fluorescence imaging. For elective CRS the overall AL in our unit is 5.08%

References:
1.       Ris E, Liot E, Buchs NC et al Multicenter phase II trial of near infrared imaging in elective colorectal surgery Br J Surg 2018;105:1359-1367
2.       Karliczek A, Harlaar NJ, Zeebregts CG et al. Surgeons lack predictive accuracy for anastomotic leakage in gastrointestinal surgery. Int J Colorectal Dis 2009;24(5):569-76
3.       Monson JR, Weiser MR, Buie WD et al. Practice parameters for the management of rectal cancer (Revised) Dis Colon Rectum. 2013;56(5):535-50.
4.       Kamal T, Pai A, Velchuru VR et al. Should anastomotic assessment with flexible sigmoidoscopy be routine following laparoscopic restorative left colorectal resection? Colorectal Dis 2015;17(2):160-4
5.       Shen R, Zhang Y, Wang T Indocyanine Green Fluorescence Angiography and the incidence of anastomotic leak after colorectal resection for colorectal cancer: A Meta Analysis. Dis Colon Rectum 2018;61(10):1228-1234
6.       Blanco-Colino R, Espin –Basany E. Intraoperative use of ICG fluorescence imaging to reduce the risk of anastomotic leakage in colorectal surgery: a systematic review and meta- analysis. Tech Coloproctol 2018;22(1):15-23
7.       Nardi De, Elmore U, Maggi G et al. Intraoperative angiography with indocyanine green to assess anastomosis perfusion in patients undergoing laparoscopic colorectal resection: results of a multicenter randomized controlled trial. Surg Endosc 2019;doi:10.1007/s00464-019-06730-0



Authors:
Dr Nitin Vashistha MS, FIAGES, FACS
Dr Dinesh Singhal MS, FACS, DNB (Surg Gastro)
Department of Surgical Gastroenterology,
Max Super Speciality Hospital, Saket, New Delhi, India
E mail: gi.cancer.india@gmail.com

Modern management of obstructive colon cancer in the background of ulcerative colitis

    An elderly patient with history of treatment for ulcerative colitis for over 2 decades presented to emergency with acute intestinal ob...